Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,362 | 6,060 | 1,038 | 1,365 | 1,378 |
| Receivables | 353 | 251 | 444 | 42 | 0 |
| Other current assets | 194 | 116 | 122 | 29 | 6 |
| TOTAL | $2,909 | $6,427 | $1,604 | $1,436 | $1,384 |
| Non-Current Assets | |||||
| PPE Net | 87 | 87 | 47 | 35 | 67 |
| Other Non-Current Assets | 20 | 20 | 25 | 4 | 309 |
| TOTAL | $107 | $107 | $72 | $40 | $375 |
| Total Assets | $3,016 | $6,534 | $1,676 | $1,475 | $1,759 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 284 | 319 | 264 | 262 | 303 |
| Accrued Expenses | 588 | 612 | 621 | 236 | 62 |
| Other current liabilities | 98 | 78 | 0 | 7 | 105 |
| TOTAL | $970 | $1,009 | $885 | $505 | $469 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 16 | 0 | 5 | 226 | 20 |
| TOTAL | $16 | $N/A | $5 | $226 | $393 |
| Total Liabilities | $986 | $1,009 | $890 | $731 | $861 |
| Shareholders' Equity | |||||
| Common Shares | 341 | 333 | 328 | 160 | 137 |
| Retained earnings | -38,408 | -34,841 | -39,094 | -38,415 | -35,992 |
| Other shareholders' equity | -5 | -5 | -6 | -31 | -26 |
| TOTAL | $2,030 | $5,525 | $786 | $744 | $898 |
| Total Liabilities And Equity | $3,016 | $6,534 | $1,676 | $1,475 | $1,759 |